Advertisement

Topics

E.M.LYON Company Profile

06:50 EDT 19th June 2018 | BioPortfolio

Founded in 1872 by the local business community, affiliated to the Lyon Chamber of Commerce and Industry, EM LYON (Ecole de Management de Lyon) is a European Institution in the French " Grande Ecole " tradition devoted to lifelong education and learning for international management.
Its mission is to serve both individuals and organisations through a broad range of programmes and learning opportunities that extend from the first degree for younger students to executive education for business leaders. Its commitment is to providing academically sound, professionally-oriented education supported by relevant research.

Location

23, av. Guy de Collongue BP 174
Ecully Cedex
69132
France

Contact

Phone: (33) 4 78 33 78 00
Fax: (33) 4 78 33 61 69
Email: exchange@em-lyon.com


News Articles [20 Associated News Articles listed on BioPortfolio]

The dinosaur menu, as revealed by calcium

(CNRS) By studying calcium in fossil remains in deposits in Morocco and Niger, researchers have been able to reconstruct the food chains of the past, thus explaining how so many predators could coexis...

Nike-Aktie: kaum Raum für Fehler vorhanden! - Aktienanalyse

Vancouver - Nike-Aktienanalyse von Analyst Camilo Lyon von Canaccord Genuity: Im Rahmen einer Aktienanalyse empfiehlt Analyst Camilo Lyon von Canaccord Genuity die Aktien des Sportartikelhersteller...

WHO director speaks on disease outbreak tactics

In a recent address to attendees of the high-level conference in Lyon, France, World Health Organization (WHO) Director-General Dr. Margaret Chan discussed how states can unite under International Hea...

Research team identifies new class of antibiotics to fight drug resistance

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of anti...

Boehringer Ingelheim to invest €65 million in avian vaccines

Boehringer Ingelheim is set to invest almost €65 million in a high-tech building at its Lyon Porte-des-Alpes site in Saint-Priest, France (Rhône), to meet the growing demand worldwide for avian va....

Erytech Pharma S.A.: ERYTECH präsentiert pharmakodynamische Daten aus der Phase-2/3-Studie von Eryaspase in ALL bei der ASCO 2018

LYON, Frankreich, 5. Juni 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien e...

Erytech Pharma S.A.: Hauptversammlung am 28. Juni 2018 und Verfügbarkeit von damit verbundenen Unterlagen

LYON, Frankreich, 07. Juni 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Ther...

Erytech Pharma S.A.: ERYTECH präsentiert auf der EHA 2018 präklinische und klinische Daten zum Einsatz von Eryaspase in und AML

LYON, Frankreich, 15. Juni 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP) (Nasdaq: ERYP) , ein in der klinischen Entwicklungsphase tätiges Biopharma-Unternehmen, das innovative Therapien...

Drugs and Medications [0 Results]

None

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Findings relevant to the QRS wave in the resting electrocardiogram are associated with circulating concentrations of high-sensitivity cardiac troponin I in the general population.

Myocardial damage could develop asymptomatically through nonischemic mechanisms such as cardiac overload. This study investigated possible associations between electrocardiogram (ECG) findings relevan...

Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014.

Respiratory syncytial virus (RSV) is a well-recognized cause of respiratory tract infections. Based on G gene variations, 11 RSV-A and 36 RSV-B genotypes have been described to date. The ON1 genotype ...

Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.

The relation between different electrocardiographic left ventricular hypertrophy (ECG-LVH) criteria and cardiovascular risk in patients with clinical manifest arterial disease is unclear. Therefore, w...

Evaluation of visual motion perception ability in mice with knockout of the dyslexia candidate susceptibility gene Dcdc2.

Developmental dyslexia is a heritable disability characterized by difficulties in learning to read and write that cannot be explained by comorbid factors such as intellectual impairment, lack of educa...

Indications and interpretation of esophageal function testing.

Esophageal symptoms are common, and can arise from mucosal, motor, functional, and neoplastic processes, among others. Judicious use of diagnostic testing can help define the etiology of symptoms and ...

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

The Use of Alternative Medicine by Palliative Care Patients

Palliative care centres in Lyon, France as well as the disclosure of Complementary and Alternative Medicine and conventional healthcare use to conventional and Complementary and Alternativ...

Studies of the Prevention of Atrial Fibrillation by ALA

An alpha-linolenic acid (ALA) rich diet in the Lyon Heart Study reduced sudden cardiac deaths possibly by reducing cardiac arrhythmias and ventricular fibrillation (Lancet 1994). Since the...

An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers

At Lyon University Medical Center, back problems are the leading cause of sick leave. The course of lower back pain is usually relatively short (recovery occurs within 4 to 6 weeks in 90% ...

Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet

An alpha linolenic acid (ALA) rich diet in the Lyon Diet Heart Study reduced sudden cardiac deaths possibly by reducing cardiac arrhythmias and ventricular fibrillation (Lancet 1994). Sin...

Ambulatory Prolapse Surgery

Day surgery is performed in the same way as in full hospital admission, allowing same-day discharge without increased risk. It provides many grounds for patient satisfaction. Progress in s...

Companies [20 Associated Companies listed on BioPortfolio]

E.M.LYON

Founded in 1872 by the local business community, affiliated to the Lyon Chamber of Commerce and Industry, EM LYON (Ecole de Management de Lyon) is a European Institution in the French " Grande Ecole "...

BioSquare 2006

Thank you for attending BioSquare 2005 in Lyon. The BioSquare organizers were able to schedule 4500 one-on-one meetings. The Partnering Section is now back online and contains all messages/requests/et...

Université Claude Bernard Lyon 1

NIL

Cabinet Plasseraud

Founded in 1906, Cabinet Plasseraud is one of the leading European firms in the IP sector, and among the largest in France. In July 2007, our firm was certified ISO 9001 in recognition of the excelle...

EuroBio

As European economies seek new solutions for continuous and competitive growth, how will technology play? What does Europe’s future in Pharma, Agriculture, Food, and the Environment look like? Europ...

More Information about "E.M.LYON" on BioPortfolio

We have published hundreds of E.M.LYON news stories on BioPortfolio along with dozens of E.M.LYON Clinical Trials and PubMed Articles about E.M.LYON for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of E.M.LYON Companies in our database. You can also find out about relevant E.M.LYON Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record